Inovio Pharmaceuticals, Inc.
VACCINES WITH INTERLEUKIN-33 AS AN ADJUVANT

Last updated:

Abstract:

Disclosed herein is a vaccine comprising an antigen and IL-33. Also disclosed herein is a method for increasing an immune response in a subject in need thereof. Further disclosed herein is a method for treating cancer in a subject in need thereof. The methods may comprise administering the vaccine to the subject.

Status:
Application
Type:

Utility

Filling date:

1 Mar 2021

Issue date:

1 Jul 2021